Protective effect of curcumin against contrast induced nephropathy in rat kidney: What is happening to oxidative stress, inflammation, autophagy and apoptosis?

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 4, 2014, Pages 461-470

  Buyuklu, M ^a   Mehmet Kandemir, F ^b   Ozkaraca, M ^b   Set, T ^c   Murat Bakirci, E ^a   Topal, E ^a  

^a ERZINCAN UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

^c ATATURK UNIVERSITY   (Turkey)

Author keywords

Angiography; Apoptosis; Autophagy; Contrast; Curcumin; Nephropathy

Indexed keywords

CATALASE; CREATININE; CURCUMIN; FUROSEMIDE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; INDOMETACIN; IOMEPROL; MALONALDEHYDE; SUPEROXIDE DISMUTASE; UREA; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; CONTRAST MEDIUM; IOPAMIDOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DEATH; CHEMICAL ANALYSIS; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; RENAL PROTECTION; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; ANIMAL; CELL PROTECTION; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; KIDNEY; KIDNEY DISEASES; METABOLISM; NEPHRITIS; PATHOLOGY; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOPTOSIS; AUTOPHAGY; BIOLOGICAL MARKERS; CONTRAST MEDIA; CURCUMIN; CYTOPROTECTION; DISEASE MODELS, ANIMAL; IOPAMIDOL; KIDNEY; KIDNEY DISEASES; MALE; NEPHRITIS; OXIDATIVE STRESS; RATS, WISTAR;

EID: 84897011251     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. ASIF A, EPSTEIN M. Prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 2004; 44: 12-24.
2. SANAEI-ARDEKANI M, MOVAHE, MR, MOVAFAGH S, GHAHRAMANI N. Contrast-induced nephropathy: a review. Cardiovasc Revasc Med 2005; 6: 82-88.
3. WONG PC, LI Z, GUO J, ZHANG A. Pathophysiology of contrast-induced nephropathy. Int J Cardiol 2012; 158: 186-192.
4. BARRETT BJ, PARFREY PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 2006; 354: 379-386.
5. SREEJAYAN N, RAO MN. Free radical scavenging activity of curcuminoids Arzneimittelforschung 1996; 46: 169-171.
6. TRUJILLO J, CHIRINO YI, MOLINA-JIJÓN E, ANDÉRICAROMERO AC, TAPIA E, PEDRAZA-CHAVERRÍ J. Renoprotective effect of the antioxidant curcumin: recent findings. Redox Biol 2013; 1: 448-456.
7. DUAN BJ, HUANG L, DING H, HUANG WY. Curcumin attenuates contrast-induced nephropathy by upregulating heme oxygenase-1 expression in rat. Zhonghua Xin Xue Guan Bing Za Zhi 2013; 41: 116-120.
8. GAZI S, ALTUN A, ERDOGAN O. Contrast-induced nephropathy: preventive and protective effects of melatonin. J Pineal Res 2006; 41: 53-57.
9. BERGMEYER HV, ED. In methods of enzymatic analysis, Academic Press, NewYork, 1983; pp. 276-286.
10. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
11. ELLMAN G. Tissue sulphydryl groups. Arch Biochem Biophys 1959; 82: 70-77.
12. BEUTLER E. Red cell metabolism. In: a manual of biochemical methods, NewYork: Grune Strottan, 1975; pp. 67-69.
13. PLACER ZA, CUSHMANNI LL, JOHNSON BC. Estimation of prod-ucts of lipid peroxidation (as malondialdehyde) in biochemical systems. Anal Biochem 1966; 16: 359-364.
14. GOERING PL, MORGAN DL, ALI SF. Effects of mercury vapor inhalation on reactive oxygen species and antioxidant enzymes in rat brain and kidney are minimal. J Appl Toxicol 2002; 22: 167-172.
15. GOLDENBERG I, MATETZKY S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 2005; 172: 1461-1471.
16. HIZOH I, HALLER C. Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress. Invest Radiol 2002; 37: 428-434.
17. TERVAHARTIALA P, KIVISAARI L, KIVISAARI R, VEHMAS T, VIRTANEN I. Structural changes in the renal proximal tubular cells induced by iodinated contrast media. Nephron 1997; 76: 96-102.
18. ALESSANDRI N, LANZI L, GARANTE CM, TERSIGNI F, SERGIACOMI R, PETRASSI M, DI MATTEO A, TUFANO F. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study. Eur Rev Med Pharmacol Sci 2013; 17: 13-21.
19. KONGKHAM S, SRIWONG S, TASANARONG A. Protective effect of alpha tocopherol on contrast-induced nephropathy in rats. Nefrologia 2013; 33: 116-123.
20. BOYACIOGLU M, TURGUT H, AKGULLU C, ERYILMAZ U, KUM C, ONBASILI OA. The efficient of L-carnitine on oxidative stress responses of experimental contrast-induced nephropathy in rat. J Vet Med Sci 2013; Aug 20.
21. ACT INVESTIGATORS. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrastinduced nephropathy Trial (ACT). Circulation 2011; 124: 1250-1259.
22. BRIGUORI C, AIROLDI F, D'ANDREA D, BONIZZONI E, MORICI N, FOCACCIO A, MICHEV I, MONTORFANO M, CARLINO M, COSGRAVE J, RICCIARDELLI B, COLOMBO A. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 2007; 115: 1211-1217.
23. SPARGIAS K, ALEXOPOULOS E, KYRZOPOULOS S, IOKOVIS P, GREENWOOD DC, MANGINAS A, VOUDRIS V, PAVLIDES G, BULLER CE, KREMASTINOS D, COKKINOS DV. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004; 110: 2837-2842.
24. POLETTI PA, SAUDAN P, PLATON A, MERMILLOD B, SAUTTER AM, VERMEULEN B, SARASIN FP, BECKER CD, MARTIN PY. I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity. Am J Roentgenol 2007; 189: 687-692.
25. PERSSON PB, PATZAK A. Renal haemodynamics alterations in contrast medium-induced nephropathy and the benefit of hydration. Nephrol Dial Transplant 2005; 20: i2-i5.
26. KOCH JA, PLUM J, GRABENSEE B, MÖDDER U. Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? PGE1 Study Group. Nephrol Dial Transplant 2000; 15: 43-49.
27. KELLY AM, DWAMENA B, CRONIN P, BERNSTEIN SJ, CARLOS RC. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 2008 148: 284-294.
28. MAIOLI M, TOSO A, LEONCINI M, GALLOPIN M, TEDESCHI D, MICHELETTI C, BELLANDI F. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 2008; 52: 29-30.
29. SCHMIDT P, PANG D, NYKAMP D, KNOWLTON G, JIA H. N-acetylcysteine and sodium bicarbonate versus n-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography. Ann Pharmacother 2006; 41: 46-50.
30. OZCAN EE, GUNERI S, AKDENIZ B, AKYILDIZ IZ, SENASLAN O, BARIS N, ASLAN O, BADAK O. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-in-duced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Am Heart J 2007; 154: 539-544.
31. FROM AM, BARTHOLMAI BJ, WILLIAMS AW, CHA SS, PFLUEGER A, MCDONALD FS. Sodium bicarbonate is associated with an increased incidence of con-trast nephropathy: A retrospective cohort study of 7977 patients at Mayo Clinic. Clin J Am Soc Nephrol 2008; 3: 10-18.
32. SOLOMON R, WERNER C, MANN D. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416-1420.
33. HUBER W, ILGMANN K, PAGE M, HENNIG M, SCHWEIGART U, JESCHKE B, LUTILSKY L, WEISS W, SALMHOFER H, CLASSEN M. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study. Radiology 2002; 223: 772-779.
34. BAGSHAW S, GHALI W. Theophylline for prevention of contrast-induced nephropathy. A systematic review and meta-analysis. Arch Intern Med 2005; 165: 1087-1093.
35. WASEEM M, PARVEZ S. Mitochondrial dysfunction mediated cisplatin induced toxicity: modulatory role of curcumin. Food Chem Toxicol 2013; 53: 334-342.
36. UEKI M, UENO M, MORISHITA J, MAEKAWA N. Curcumin ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in mice. J Biosci Bioeng 2013; 115: 547-551.
37. KUMARAVEL M, SANKAR P, RUKKUMANI R. Antiproliferative effect of an analog of curcumin bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione in human breast cancer cells. Eur Rev Med Pharmacol Sci 2012; 16: 1900-1907.
38. SAGIROGLU T, KANTER M, YAGCI MA, SEZER A, ERBOGA M. Protective effect of curcumin on cyclosporin Ainduced endothelial dysfunction, antioxidant capacity, and oxidative damage. Toxicol Ind Health 2013; Jul 18 [Epub ahead of print].
39. ARI E, KEDRAH AE, ALAHDAB Y, BULUT G, EREN Z, BAYTEKIN O, ODABASI D. Antioxidant and renoprotective effects of paricalcitol on experimental contrast-induced nephropathy model. Br J Radiol 2012; 85: 1038-1043.
40. TOPRAK O, CIRIT M, TANRISEV M, YAZICI C, CANOZ O, SIPAHIOGLU M, UZUM A, ERSOY R, SOZMEN EY. Preventive effect of nebivolol on contrast-induced nephropathy in rats. Nephrol Dial Transplant 2008; 23: 853-859.
41. EFRATI S, DISHY V, AVERBUKH M, BLATT A, KRAKOVER R, WEISGARTEN J, MORROW JD, STEIN MC, GOLIK A. The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography. Kidney Int 2003; 64: 2182-2187.
42. SUGIMOTO H, SHIKATA K, WADA J, HORIUCHI S, MAKINO H. Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factoralpha and inducible nitric oxide synthase in diabetic rat glomeruli. Diabetologia 1999; 42: 878-886.
43. TRACHTMAN H, FUTTERWEIT S, PINE E, MANN J, VALDERRAMA E. Chronic diabetic nephropathy: Role of inducible nitric oxide synthase. Pediatr Nephrol 2002; 17: 20-29.
44. MANIKANDAN R, BEULAJA M, THIAGARAJAN R, PRIYADARSINI A, SARAVANAN R, ARUMUGAM M. Ameliorative effects of curcumin against renal injuries mediated by inducible nitric oxide synthase and nuclear factor kappa B during gentamicin-induced toxicity in Wistar rats. Eur J Pharmacol 2011; 670: 578-585.
45. SU M, MEI Y, SINHA S. Role of the Crosstalk between Autophagy and Apoptosis in Cancer. J Oncol 2013; 2013: 102735.
46. SERVAIS H, ORTIZ A, DEVUYST O, DENAMUR S, TULKENS PM, MINGEOT-LECLERCQ MP. Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation. Apoptosis 2008; 13: 11-32.
47. YANO T, ITOH Y, SENDO T, KUBOTA T, OISHI R. Cyclic AMP reverses radiocontrast media-induced apoptosis in LLC-PK1 cells by activating A kinase/PI3 kinase. Kidney Int 2003; 64: 2052-2063.
48. WHITE E, DIPAOLA RS. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 2009; 15: 5308-5316.
49. RUBINSZTEIN DC, CUERVO AM, RAVIKUMAR B, SARKAR S, KOROLCHUK V, KAUSHIK S, KLIONSKY DJ. In search of an "autophagomometer". Autophagy 2009; 5: 585-589.
50. FUNK JA, SCHNELLMANN RG. Persistent disruption of mitochondrial homeo-stasis after acute kidney injury. Am J Physiol Renal Physiol 2012; 302: 853-864.
51. KIMURA T, TAKABATAKE Y, TAKAHASHI A, KAIMORI JY, MATSUI I, NAMBA T, KITAMURA H, NIIMURA F, MATSUSAKA T, SOGA T, RAKUGI H, ISAKA Y. Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J Am Soc Nephrol 2011; 22: 902-913.
52. DOMITROVI R, CVIJANOVI O, PERNJAK-PUGEL E, SKODA M, MIKELI L, CRN EVI-ORLI Z. Berberine exerts nephroprotective effect against cisplatin-induced kidney damage through inhibition of oxidative/nitrosative stress, inflammation, autophagy and apoptosis. Food ChemToxicol 2013; 62: 397-406.